Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: A study of the United Kingdom Medical Research Council Adult Leukaemia Working Party

British Journal of Haematology

Volumn 146, Issue 1, 2009, Pages 54-63

  Wheatley, Keith ^a   Goldstone, Anthony H ^b   Littlewood, Tim ^c   Hunter, Anne ^d   Burnett, Alan K ^e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

AML; G CSF; Growth factor; Induction; Randomized trial

Indexed keywords

ANTIBIOTIC AGENT; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG TREATMENT FAILURE; HUMAN; INFECTION; LENGTH OF STAY; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GREAT BRITAIN; HUMANS; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67049158422     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07710.x     Document Type: Article

References (29)

1. Amadori, S., Suciu, S., Jehn, U., Stasi, R., Thomas, X., Marie, J.P., Muus, P., Lefrere, F., Berneman, Z., Fillet, G., Denzlinger, C., Willemze, R., Leoni, P., Leone, G., Casini, M., Ricciuti, F., Vignetti, M., Beeldens, F., Mandelli, F. De Witte, T., for the EORTC/GIMEMA Leukemia Group (2005) Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. Blood, 106, 27 34. (Pubitemid 40967170)
2. Baer, M.R., Bernstein, S.H., Brunetto, V.L., Heinonen, K., Mrozek, K., Swann, V.L., Minderman, H., Block, A.W., Pixley, L.A., Christiansen, N.P., Fay, J.W., Barcos, M., Rustum, Y., Herzig, G.P. Bloomfield, C.D. (1996) Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukaemia. Blood, 87, 1484 1494. (Pubitemid 26056913)
3. Begley, C.G., Metcalf, D. Nicola, N.A. (1987) Primary human myeloid leukaemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia, 1, 1 8. (Pubitemid 17152855)
4. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. Sultan, C. (1976) Proposals for the classification of the acute leukaemias (FAB cooperative group). British Journal of Haematology, 33, 451 458.
5. Burnett, A.K., Wheatley, K., Goldstone, A.H., Gibson, B., Webb, D., Prentice, A.G. Milligan, D.W. (2002) MRC AML12: a comparison of ADE vs MAE and S-DAT vs H-DAT ± retinoic acid for induction and four vs five total courses using chemotherapy or stem cell transplant in consolidation, in 3459 patients under 60 years with AML. Blood, 100, 155a, Abstract 582.
6. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A. Degos, L. (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. New England Journal of Medicine, 332, 1678 1683.
7. Frankfurt, O. Tallman, M.S. (2007) Growth factors in leukemia. Journal of the National Comprehensive Cancer Network, 5, 203 215. (Pubitemid 46423059)
8. Godwin, J.E., Kopecky, K.J., Head, D.R., Willman, C.L., Leith, C.P., Hynes, H.E., Balcerzak, S.P. Appelbaum, F. (1998) A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (9031). Blood, 91, 3607 3615. (Pubitemid 28225726)
9. Goldstone, A.H., Burnett, A.K., Wheatley, K., Smith, A.G., Hutchinson, R.M. Clark, R.E. (2001) Attempts to improve treatment outcomes in acute myeloid leukaemia in older patients: the results of the UK Medical Research Council AML11 Trial. Blood, 98, 1302 1311.
10. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Rees, J., Hann, I., Stevens, R., Burnett, A. Goldstone, A. (1998) The importance of cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood, 92, 2322 2333. (Pubitemid 28452973)
11. Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K.H., Wheatley, K., Gray, R.G. Burnett, A.K. (1997) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia. Results of the Medical Research Council's 10th AML Trial (MRC AML 10). Blood, 89 (7 2311 2318. (Pubitemid 27143277)
12. Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Liu Yin, J.A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., Matcham, J. Barge, A. (1997) A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood, 90, 4710 4718. (Pubitemid 28007183)
13. Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Noens, L., Szer, J., Ganser, A., Matcham, J. Renwick, J., for the International Acute Myeloid Leukemia Study Group (2006) Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia. Leukemia, 20, 404 409. (Pubitemid 43291736)
14. Löwenberg, B. (1996) Treatment of the Elderly Patient with Acute Myeloid Leukaemia (ed): Acute Myelogenous Leukemia and Myelodysplasia. Bailliere's Clinical Haematology (Vol 9), pp. 47. Sanders, London, UK.
15. Löwenberg, B., Suciu, S., Archimbaud, E., Ossenkoppele, G., Verhoef, G.E.G., Vellenga, E., Wijermans, P., Berneman, Z., Dekker, A.W., Stryckmans, P., Schouten, H., Jehn, U., Muus, P., Sonneveld, P., Dardenne, M. Zittoun, R. (1997) Use of recombinant granulocyte-macrophage colony-stimulationg factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON). Blood, 90, 2952 2961.
16. Löwenberg, B., van Putten, W., Theobald, M., Gmür, J., Verdonck, L., Sonneveld, P., Fey, M., Schouten, H., de Greef, G., Ferrant, A., Kovacsovics, T., Gratwohl, A., Daenen, S., Huijgens, P. Boogaerts, M. (2003) Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. New England Journal of Medicine, 349, 743 752. (Pubitemid 37010778)
17. Mayder, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. Frei, E. (1994) Intensive postremission chemotherapy in adults with acute myeloid leukaemia. New England Journal of Medicine, 331, 896 942.
18. Milligan, D.W., Wheatley, K., Littlewood, T., Craig, J.I.O. Burnett, A.K. (2006) Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood, 107, 4614 4622. (Pubitemid 43882605)
19. Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., Morishima, Y., Saito, Y., Furusawa, S., Imai, K., Takemoto, Y., Miura, Y., Teshima, H. Hamajima, N. & the Kohseisho Leukemia Study Group 1994) A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood, 83, 2086 2092. (Pubitemid 24112719)
20. Park, L.S., Waldron, P.E., Friend, D., Sassenfeld, H.M., Price, V., Anderson, D., Cosman, D., Andrews, R.G., Bernstein, I.D. Urdal, D.L. (1989) Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood, 74, 56 65. (Pubitemid 19187410)
21. Ravandi, F. (2006) Role of cytokines in the treatment of acute leukemias: a review. Leukemia, 20, 563 571.
22. Rowe, J.M., Anderson, J.W., Mazza, J.J., Bennett, J.M., Paietta, E., Hayes, F.A., Oette, D., Cassileth, P.A., Stadtmauer, E.A. Wiernik, P.H. (1995) A randomized placebo-controlled phase III study of granulocyte-macrophage colony stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukaemia: a study of the Eastern European Oncology Group (E1490). Blood, 86, 457 462.
23. Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B.L. Schiffer, C.A. (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New England Journal of Medicine, 332, 1671 1677.
24. Te Boekhorst, P.A.W., Löwenberg, B., Vlastuin, M. Sonneveld, P. (1993) Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukaemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia, 7, 1191 1198. (Pubitemid 23256468)
25. Thomas, X., Raffoux, E., Botton, S., Pautas, C., Arnaud, P., de Revel, T., Reman, O., Terre, C., Corront, B., Gardin, C., Le, Q.H., Quesnel, B., Cordonnier, C., Bourhis, J.H., Elhamri, M., Fenaux, P., Preudhomme, C., Michallet, M., Castaigne, S. Dombret, H. (2007) Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group. Leukemia, 21, 453 461. (Pubitemid 46306556)
26. Wadleigh, M. Stone, R.M. (2009) The role of myeloid growth factors in acute leukemia. Journal of the National Comprehensive Cancer Network, 7, 84 91.
27. Witz, F., Sadoun, A., Perrin, M.-C., Berthou, C., Brière, J., Cahn, J.-Y., Lioure, B., Witz, B., François, S., Desablens, B., Pignon, B., Le Prisé, P.-Y., Audhuy, B., Caillot, D., Casassus, P., Delain, M., Christian, B., Tellier, Z., Polin, V., Hurteloup, P. Harousseau, J.-L. (1998) A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Blood, 91, 2722 2730. (Pubitemid 28227521)
28. Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Stryckmans, P., Rotoli, B., Leoni, P., Peetermans, M.E., Dardenne, M., Vegna, M.L., Petti, M.C., Solbu, G. Suciu, S. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New England Journal of Medicine, 332, 217 223.
29. Zittoun, R., Suciu, S., Mandelli, F., de Witte, T., Thaler, J., Stryckmans, P., Hayat, M., Peetermans, M., Cadiou, M., Solbu, G., Petti, M.C. Willemze, R. (1996) Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. Journal of Clinical Oncology, 14, 2150 2159. (Pubitemid 26230119)